Over a quarter ago |
Downgrade
|
Ladenburg analyst… Ladenburg analyst Christopher Nolan downgraded New York Mortgage to Neutral from Buy and removed the firm's previous $3 price target given the view that the current quarterly dividend payout is not secure. The firm, which is "increasingly cautious" on New York Mortgage's real estate exposure, is modeling for a quarterly payout of 8c per share beginning in Q1, versus 10c per share in Q4. ShowHide Related Items >><< - 10/17/22
- New York Mortgage reports book value per share $3.62-$3.66 at Sept. 30
- 12/19/22 JonesResearch
- New York Mortgage price target lowered to $3.50 from $4 at JonesTrading
- 10/25/22 B. Riley
- New York Mortgage price target lowered to $5 from $5.50 at B. Riley
- 07/17/22 Barclays
- New York Mortgage price target lowered to $3 from $3.50 at Barclays
- 07/17/22 Keefe Bruyette
- New York Mortgage downgraded to Market Perform at Keefe Bruyette
- 02/22/23
- New York Mortgage reports Q4 EPS (13c), consensus 0c
- 11/02/22
- New York Mortgage reports Q3 EPS (33c), consensus (4c)
- 02/03/23
- Sell these stocks now, proven algorithm says
- 11/18/22
- Sell these stocks now, proven algorithm says
- 09/16/22
- Sell these stocks now, proven algorithm says
|
Earnings
|
Reports Q4 funding of… Reports Q4 funding of approximately $106M of portfolio investments. Repurchased $50M par value of residential loan securitization CDOs for approximately $46.5M. Received approximately $36.2M in proceeds from redemptions of Mezzanine Lending investments.The company also completed a securitization of residential loans, resulting in approximately $232M in net proceeds to the Company after deducting expenses associated with the transaction. The Company utilized the net proceeds to repay outstanding repurchase agreement financing related to residential loans. ShowHide Related Items >><< - 10/17/22
- New York Mortgage reports book value per share $3.62-$3.66 at Sept. 30
- 12/19/22 JonesResearch
- New York Mortgage price target lowered to $3.50 from $4 at JonesTrading
- 10/25/22 B. Riley
- New York Mortgage price target lowered to $5 from $5.50 at B. Riley
- 07/17/22 Barclays
- New York Mortgage price target lowered to $3 from $3.50 at Barclays
- 07/17/22 Keefe Bruyette
- New York Mortgage downgraded to Market Perform at Keefe Bruyette
- 11/02/22
- New York Mortgage reports Q3 EPS (33c), consensus (4c)
- 02/03/23
- Sell these stocks now, proven algorithm says
- 11/18/22
- Sell these stocks now, proven algorithm says
- 09/16/22
- Sell these stocks now, proven algorithm says
|
On The Fly
| ShowHide Related Items >><< - 01/17/23
- Welltower announces executive and senior leadership promotions
- 11/07/22
- Welltower announces formation of JV with Integra Health
- 01/31/23
- Western Digital falls 7% to $41.00 per share after Q2 earnings miss and guidance
- 01/31/23
- Western Digital enters $900M convertible preferred equity investment by Apollo
- 10/26/22
- Kioxia, Western Digital open semiconductor fabrication facility Fab7 in Japan
- 08/31/22
- Western Digital, Micron lower in pre-market after Seagate guidance cut
- 01/10/23
- RMI launches virtual power plant partnership with GM, Google, Ford
- 11/10/22
- California issues revised proposal on rooftop solar subsidies
- 11/01/22
- Sunrun to build, operate Puerto Rico's first VPP
- 10/13/22
- Sunrun, Enel X partner to offer smart electric vehicle home charging stations
RADI Radius Global Infrastructure - 11/30/22
- Radius Global Infrastructure trading resumes
- 11/30/22
- Radius Global jumps 13%, halted after Bloomberg report on takeover talks
- 11/30/22
- Radius Global Infrastructure trading halted, volatility trading pause
- 11/08/22
- Radius Global Infrastructure backs FY22 Acquisition CapEx view at least $400M
- 01/18/23
- Paysafe enters Ohio online sports-betting market
- 12/14/22
- Paysafe falls -9.9%
- 12/14/22
- Paysafe falls -8.5%
- 12/08/22
- Paysafe announces reverse stock split
- 01/03/23
- Planet Labs announces successful launch of 36 SuperDove satellites
- 12/16/22
- Planet Labs rises 10.2%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 10/17/22
- New York Mortgage reports book value per share $3.62-$3.66 at Sept. 30
- 10/20/22
- Chewy expands CarePlus with new plan by Lemonade Pet
- 10/03/22
- Lemonade launches in the United Kingdom
- 08/08/22
- Lemonade jumps 11% to nearly $28 after Q2 report
- 08/08/22
- Lemonade jumps 11% to nearly $28 after Q2 report
- 02/01/23
- Illumina appoints Joydeep Goswami as CFO
- 01/09/23
- Illumina, Nashville Biosciences announce sequencing agreement with Amgen
- 12/05/22
- European Commission says Illumina has to unwind Grail acquisition
- 02/02/23
- Guardant Health, AnHeart Therapeutics team on NSLC companion diagnostics
- 02/02/23
- Guardant Health 'pleased' with ruling in Illumina case
- 01/30/23
- FDA okays Guardant360 as companion diagnostic in patients with ESR1 mutations
- 01/19/23
- Guardant Health partners with The Royal Marsden NHS Foundation for TRACC study
- 01/11/23
- Geron announces multiple additions to senior commercial leadership team
- 01/04/23
- Geron up 48% in pre-market at $3.54 after Phase 3 trial data for imetelstat
- 01/04/23
- Geron reports 'positive' results from IMerge Phase 3 trial of imetelstat
- 08/22/22
- Geron doses first patient in IMproveMF phase 1 study
- 01/17/23
- First Republic announces 12-person team joined First Republic Investment
- 01/10/23
- First Republic appoints team as Managing Directors, Wealth Managers
- 10/14/22
- First Republic falls -14.5%
- 10/14/22
- First Republic falls -6.3%
- 01/19/23
- Compass falls -9.7%
- 11/22/22
- Redfin says investor home purchases fell 30.2% YoY nationwide in Q3
- 11/11/22
- Compass rises 51.0%
- 11/10/22
- Redfin says annual home price growth slows to 3%
- 01/25/23
- Millicom confirms talks with Apollo, Claure Group about potential transaction
- 12/27/22
- Apollo Global names Tatsuo Tanaka as Japan Chair
- 12/15/22
- Apollo funds provide $200M to WEC Energy renewable porfolio
- 11/29/22
- Atlas Air Worldwide shareholders approve of proposed acquisition by Apollo
- $26.41 /
+4.445 (+20.24%) - 02/03/23
- C3.ai rises 21.2%
- 01/31/23
- C3.ai rises 25.2%
- 01/31/23
- C3.ai rises 18.8%
- 01/31/23
- C3.ai rises 12.6%
- $26.41 /
+4.445 (+20.24%) - 02/02/23 DA Davidson
- C3.ai initiated with a Buy at DA Davidson
- 12/08/22 Morgan Stanley
- C3.ai price target lowered to $12 from $13 at Morgan Stanley
- 12/08/22 Piper Sandler
- C3.ai price target lowered to $13 from $14 at Piper Sandler
- 12/08/22 Deutsche Bank
- C3.ai price target lowered to $11 from $13 at Deutsche Bank
- 02/01/23 Craig-Hallum
- Western Digital price target raised to $60 from $50 at Craig-Hallum
- 02/01/23 Mizuho
- Western Digital price target lowered to $35 from $38 at Mizuho
- 01/23/23 Exane BNP Paribas
- Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas
- 01/06/23 Benchmark
- Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report
- 01/09/23 Raymond James
- Welltower upgraded to Strong Buy from Outperform at Raymond James
- 12/27/22 Raymond James
- Welltower selloff from short report brings opportunity, says Raymond James
- 12/09/22 Raymond James
- Welltower price target raised to $72 from $70 at Raymond James
- 12/08/22 Morgan Stanley
- Welltower Integra JV risk not a 'thesis changer,' says Morgan Stanley
- 12/02/22 UBS
- Compass initiated with a Neutral at UBS
- 09/01/22 Needham
- Needham says Compass is 'preferred way' to play difficult real estate market
- 08/16/22 Barclays
- Compass price target lowered to $5 from $7 at Barclays
- 07/21/22 Morgan Stanley
- Compass downgraded to Equal Weight from Overweight at Morgan Stanley
RADI Radius Global Infrastructure - 12/16/22 RBC Capital
- Radius Global Infrastructure initiated with a Sector Perform at RBC Capital
- 12/14/22 Exane BNP Paribas
- Radius Global Infrastructure initiated with an Outperform at Exane BNP Paribas
- 10/04/22 Raymond James
- Radius Global Infrastructure price target lowered to $17 from $21 at Raymond James
- 05/10/22 Raymond James
- Radius Global Infrastructure price target raised to $22 from $18 at Raymond James
- 01/06/23
- Gordon Haskett wonders if Guardant could be 'shoehorned' into Agilent search
- 01/05/23 Scotiabank
- Guardant Health initiated with an Outperform at Scotiabank
- 01/04/23 Scotiabank
- Guardant Health initiated with an Outperform at Scotiabank
- 12/16/22 Goldman Sachs
- Goldman says Guardant selloff, Exact Science rally an overreaction
- 01/17/23 Maxim
- First Republic price target lowered to $185 from $200 at Maxim
- 01/15/23 Raymond James
- First Republic price target raised to $150 from $142 at Raymond James
- 01/09/23 Jefferies
- First Republic upgraded to Buy from Hold at Jefferies
- 01/05/23 Goldman Sachs
- First Republic upgraded to Buy from Neutral at Goldman Sachs
- 12/19/22 JonesResearch
- New York Mortgage price target lowered to $3.50 from $4 at JonesTrading
- 10/25/22 B. Riley
- New York Mortgage price target lowered to $5 from $5.50 at B. Riley
- 07/17/22 Barclays
- New York Mortgage price target lowered to $3 from $3.50 at Barclays
- 07/17/22 Keefe Bruyette
- New York Mortgage downgraded to Market Perform at Keefe Bruyette
- 01/23/23 Morgan Stanley
- Planet Labs initiated with an Equal Weight at Morgan Stanley
- 12/19/22 Northland
- Maxar deal sheds light on growing value of Planet Labs data, says Northland
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 01/30/23 Goldman Sachs
- Sunrun price target lowered to $37 from $40 at Goldman Sachs
- 01/25/23 Barclays
- Sunrun downgraded to Equal Weight from Overweight at Barclays
- 01/06/23 Wells Fargo
- Sunrun upgraded to Overweight from Equal Weight at Wells Fargo
- 12/15/22 JPMorgan
- JPMorgan shuffles Focus List, names top 2023 alternative energy picks
- 01/09/23 B. Riley
- Geron price target raised to $5 from $4 at B. Riley
- 01/04/23 Wedbush
- Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
- 10/28/22 Wedbush
- Wedbush starts Geron with Outperform, $5 price target
- 10/27/22 Wedbush
- Geron initiated with an Outperform at Wedbush
- 01/19/23 BMO Capital
- Lemonade initiated with an Underperform at BMO Capital
- 01/18/23 Piper Sandler
- Lemonade price target lowered to $19 from $20 at Piper Sandler
- 11/17/22 Keefe Bruyette
- Lemonade initiated with a Market Perform at Keefe Bruyette
- 11/10/22 Barclays
- Lemonade price target lowered to $18 from $28 at Barclays
- 08/31/22 Susquehanna
- Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see'
- 08/31/22 Susquehanna
- Paysafe downgraded to Neutral from Positive at Susquehanna
- 08/11/22 Credit Suisse
- Paysafe downgraded to Underperform from Neutral at Credit Suisse
- 08/10/22 RBC Capital
- Paysafe downgraded to Sector Perform from Outperform at RBC Capital
- 01/27/23 Piper Sandler
- Illumina price target lowered to $290 from $300 at Piper Sandler
- 01/25/23 Argus
- Illumina downgraded to Hold at Argus on valuation, deteriorating outlook
- 01/25/23 Argus
- Illumina downgraded to Hold from Buy at Argus
- 01/17/23 Canaccord
- Illumina price target lowered to $300 from $330 at Canaccord
- 01/31/23 BMO Capital
- Franklin Resources price target raised to $23 from $22 at BMO Capital
- 01/12/23 Barclays
- Apollo Global price target raised to $85 from $78 at Barclays
- 01/02/23 Keefe Bruyette
- Apollo Global downgraded to Market Perform from Outperform at Keefe Bruyette
- 12/19/22 Barclays
- Apollo Global price target raised to $78 from $73 at Barclays
- 11/07/22
- Welltower sees Q4 normalized FFO 80c-85c
- 11/07/22
- Welltower reports Q3 normalized FFO 84c, consensus 84c
- 10/04/22
- Welltower: Q3 FFO trending below midpoint of 82c-87c view
- 08/09/22
- Welltower sees Q3 normalized FFO 82c-87c
- 01/31/23
- Western Digital sees Q3 EPS ($1.70) to ($1.40), consensus (30c)
- 01/31/23
- Western Digital reports Q2 EPS (42c), consensus (12c)
- 01/31/23
- Notable companies reporting after market close
- 10/27/22
- Western Digital sees Q2 EPS (25c)-5c, consensus 34c
- 11/02/22
- Sunrun sees Net Subscriber Value increasing sequentially in Q4 from Q3
- 11/02/22
- Sunrun reports Q3 diluted EPS 96c, may not compare to consensus (9c)
- 11/02/22
- Notable companies reporting after market close
- 08/03/22
- Sunrun reports Q2 EPS (6c), consensus (10c)
RADI Radius Global Infrastructure - 11/08/22
- Radius Global Infrastructure reports Q3 EPS 23c, consensus (26c)
- 11/10/22
- Paysafe sees Q4 revenue $370M-$378M, consensus $370.81M
- 11/10/22
- Paysafe raises FY22 revenue view to $1.48B-$1.49B from $1.47B-$1.49B
- 11/10/22
- Paysafe reports Q3 EPS 0c, consensus 0c
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/02/22
- New York Mortgage reports Q3 EPS (33c), consensus (4c)
- 11/08/22
- Lemonade sees Q4 revenue $77M-$80M, consensus $80.73M
- 11/08/22
- Lemonade sees FY22 revenue $245M-$248M, consensus $236.91M
- 11/08/22
- Lemonade reports Q3 EPS ($1.37), consensus ($1.32)
- 08/08/22
- Lemonade raises FY22 revenue view to $236M-$239M, consensus $213.41M
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 11/03/22
- Illumina reports Q3 adjusted EPS 34c, consensus 30c
- 11/03/22
- Notable companies reporting after market close
- 10/03/22
- Illumina sees giving detailed FY23 guidance in February
- 01/09/23
- Guardant Health sees FY22 revenue $447M-$450M, consensus $445.24M
- 01/09/23
- Guardant Health sees Q4 revenue $124M-$127M , consensus $122.68M
- 11/03/22
- Guardant Health cuts FY22 revenue view to $440M-$460M, consensus $461.29M
- 11/03/22
- Guardant Health reports Q3 adjusted EPS ($1.18), consensus ($1.26)
- 11/03/22
- Geron reports Q3 EPS (10c), consensus (9c)
- 08/11/22
- Geron reports Q2 EPS (7c), consensus (9c)
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 11/10/22
- Compass lowers FY22 revenue view to $6.05B-$6.20B from $6.15B-$6.45B
- 11/10/22
- Compass sees Q4 revenue $1.15B-$1.30B, consensus $1.41B
- 11/10/22
- Compass reports Q3 EPS (36c), consensus (34c)
- 08/15/22
- Compass sees FY22 revenue $6.15B-$6.45B, consensus $7.59B
- 11/02/22
- Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year
- 11/01/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Apollo Global reports Q2 adjusted EPS 94c, consensus $1.02
- $26.41 /
+4.445 (+20.24%) - 12/07/22
- C3.ai backs FY23 revenue view of $255M-$270M, consensus $260.8M
- 12/07/22
- C3.ai sees Q3 revenue $63.0M-$65.0M, consensus $66.8M
- 12/07/22
- C3.ai reports Q2 EPS (11c), consensus (16c)
- 08/31/22
- C3.ai cuts FY23 revenue view to $255M-$270M from $308M-$316M
|
Recommendations
|
JonesTrading analyst… JonesTrading analyst Jason Stewart lowered the firm's price target on New York Mortgage to $3.50 from $4 and keeps a Buy rating on the shares. The analyst has turned constructive on the medium-term outlook for agency mortgage real estate investment trusts. Fixed income volatility is set to decline as the Federal Reserve approaches cycle terminal fed funds rates, which should tighten the mortgage basis through 2023, albeit not linearly, Stewart tells investors in a research note. He says high quality, liquid assets should perform well against this backdrop. ShowHide Related Items >><< - 10/17/22
- New York Mortgage reports book value per share $3.62-$3.66 at Sept. 30
- 10/25/22 B. Riley
- New York Mortgage price target lowered to $5 from $5.50 at B. Riley
- 07/17/22 Barclays
- New York Mortgage price target lowered to $3 from $3.50 at Barclays
- 07/17/22 Keefe Bruyette
- New York Mortgage downgraded to Market Perform at Keefe Bruyette
- 04/27/22 Barclays
- New York Mortgage price target lowered to $3.50 from $4 at Barclays
- 11/02/22
- New York Mortgage reports Q3 EPS (33c), consensus (4c)
- 08/02/22
- New York Mortgage reports Q2 EPS (22c), consensus 1c
- 11/18/22
- Sell these stocks now, proven algorithm says
- 09/16/22
- Sell these stocks now, proven algorithm says
- 07/18/22
- What You Missed On Wall Street On Monday
- 07/18/22
- What You Missed On Wall Street This Morning
|
On The Fly
| ShowHide Related Items >><< - 11/09/22
- Zentalis expects cash to fund requirements into 1Q25
- 11/08/22
- Zai Lab appoints Huang as Chief Scientific Officer
- 10/24/22
- Zentalis announces first ZN-c3 clinical development collaboration with Pfizer
- 10/17/22
- Zentalis appoints Lackner as Chief Translational Officer
- 11/01/22
- Macau reports October casino revenue down 10.7% to 3.9B patacas
- 10/31/22
- Wynn Resorts higher after Fertitta takes 6.1% passive stake
- 10/27/22
- Nevada reports September statewide gaming win up 7.87% to $1.25B
- 10/18/22
- New Jersey reports September gaming revenue up 6.9% to $485M
- 11/10/22
- Warby Parker rises 21.2%
- 09/26/22
- Warby Parker rises 8.7%
- 08/11/22
- Warby Parker rises 19.3%
- 08/11/22
- Warby Parker rises 19.9%
- 11/02/22
- Cathie Wood's ARK Investment bought 156K shares of Unity today
- 11/01/22
- Cathie Wood's ARK Investment bought 332.6K shares of Unity today
- 10/24/22
- Cathie Wood's ARK Investment bought 19.6K shares of Unity today
- 09/13/22
- Unity falls -11.3%
- 07/28/22
- Nuscale Power signs Business Collaboration Agreement with NTS
- 07/12/22
- Nuscale Power and Paragon Energy sign license agreement for HIPS platform
- 06/22/22
- Lightbridge announces Massachusetts MIT awarded $800,000 by DOE
- 06/20/22
- NuScale announces strategic shift to product services and delivery organization
- 11/03/22
- Cassava files lawsuit against perpetrators of 'short and distort' campaign
- 10/27/22
- Cassava Sciences appoints Cook as SVP, general counsel
- 10/13/22
- Cassava Sciences initiates open-label extension simufilam study
- 10/12/22
- Cassava enrolling open-label extension for Phase 3 simufilam trials
- 11/10/22
- Royal Caribbean opens $125M cruise terminal in Galveston with Allure of the Seas
- 11/03/22
- Royal Caribbean sees returning to historical load factors in early summer 2023
- 11/03/22
- Royal Caribbean: Trifecta program to increase adjusted EPS to double digits
- 11/03/22
- Royal Caribbean: FY23 booked well within historical ranges
- 11/15/22
- Paysafe launches paysafecard as alternative payment on Microsoft.com, Xbox.com
- 10/19/22
- Paysafe announces new integrated payments partnership with HotelKey
- 09/26/22
- Paysafe announces entry into Kansas online sports-betting market
- 09/21/22
- Paysafe enters new partnership with Spreedly
- 11/15/22
- Microsoft, Planet to provide AI and satellite data for African climate projects
- 11/11/22
- Planet Labs expands board
- 10/13/22
- Planet Labs announces NASA exercises option to extend contract
- 09/14/22
- Planet Labs teams with Taylor Geospatial for studies on food security, defense
PCT PureCycle Technologies - 11/09/22
- PureCycle Technologies provides Q3 update
- 08/11/22
- PureCycle Technologies provides Q2 operational update
- 06/30/22
- PureCycle CEO Mike Otworth to resign, Dustin Olson promoted to CEO
- 10/26/22
- Oatly Group announces partnership with Aral
- 09/27/22
- Oatly Group debuts YouTube cooking show 'Will it Swap?'
- 06/16/22
- Oatly Group announce results of 2022 Annual General Meeting
- 06/09/22
- Oatly introduces electric heavy duty trucks to fleet in North America
- 10/17/22
- New York Mortgage reports book value per share $3.62-$3.66 at Sept. 30
- 10/25/22
- Monday.com opens latest North American office in Chicago
- 10/11/22
- Monday.com expands global presence with office in Marunouchi, Tokyo
- 09/20/22
- Monday.com opens North American headquarters in NYC
- 11/14/22
- Third Point buys TJX, exits Cenovus Energy in Q3
- 10/17/22
- Archaea Energy rises 53.2%
- 10/17/22
- Archaea Energy rises 52.3%
- 10/17/22
- Archaea Energy rises 52.5%
- 08/12/22
- Soros adds Biohaven, exits Lucid in Q2
- 07/18/22
- Indie Semiconductor opens engineering center of excellence
- 06/14/22
- Indie Semiconductor CEO: We'll cross over the profitability barrier in 2023
- 06/13/22
- Indie Semiconductor set to join Russell 2000 Index on June 27
- 11/16/22
- Inhibrx's chondrosarcoma candidate shows efficacy and safety in Phase 1 trial
- 10/04/22
- Inhibrx announce potential to pursue accelerated approval in U.S. for INBRX-101
- 08/15/22
- Inhibrx: EMA grants orphan drug designation to INBRX-109
- 06/30/22
- Inhibrx completes Phase 1 dose escalation for INBRX-105, draws $60M loan
- 11/08/22
- U.S. video game spending fell 5% y/y in Q3, says NPD
- 10/31/22
- GameStop's NFT marketplace launches with ImmutableX
- 10/31/22
- GameStop rises 11.8%
- 10/31/22
- GameStop trading resumes
- 11/11/22
- Freyr Battery announces plan for Georgia Gigafactory
- 10/27/22
- Freyr Battery, ITOCHU partner to develop materials supply chain
- 10/10/22
- Freyr Battery signs license, services agreement with Aleees
- 09/21/22
- Freyr Battery rises 15.9%
- 11/14/22
- 3D Systems announces addition of two new materials to its materials portfolio
- 11/10/22
- 3D Systems, ALM announce partnership to expand access to 3D printing materials
- 09/12/22
- 3D Systems adds chief corporate development officer to Andrew Johnson's title
- 09/08/22
- 3D Systems forms new company Systemic Bio, invests $15M
- 11/11/22
- Compass rises 51.0%
- 11/10/22
- Redfin says annual home price growth slows to 3%
- 11/01/22
- New York Attorney General announces agreement with Compass
- 10/28/22
- Compass names Kalani Reelitz as CFO
- 11/09/22
- Celldex sees cash, equivalents sufficient to meet requirements through 2025
- 07/21/22
- Celldex announces first patient dosed in Phase 2 study of barzolvolimab
- 06/30/22
- Celldex presents positive Phase 1b interim data from barzolvolimab
- 06/21/22
- Celldex announces first patient dosed in Phase 2 study of barzolvolimab
- 10/25/22
- Canopy Growth to acquire Acreage Holdings via Floating Share arrangement
- 10/25/22
- Canopy Growth creates holding company to enter U.S. cannabis market
- 10/25/22
- Constellation Brands to convert common stock holding in Canopy Growth
- 10/06/22
- President Biden says taking steps on marijuana reform
- 10/03/22
- Bilibili announces primary listing on Hong Kong stock exchange
- 11/03/22
- Beam Therapeutics to present ESCAPE approach data at ASH
- 11/03/22
- Beam Therapeutics receives multiple orders from U.S. Marine Corps
- 09/19/22
- Beam Therapeutics presents in vivo data on multiplex base editing approach
- 08/01/22
- Beam Therapeutics drops 12% to $54.99 after FDA places hold on BEAM-201 IND
- 11/08/22
- Affirm CEO: We grew on every metric we care about
- 11/08/22
- Affirm says slowing economy, worsening consumer credit to hamper GMV growth
- 11/08/22
- Affirm reports Q1 Gross Merchandise Volume up 62% y/y at $4.4B
- 11/08/22
- Affirm falls 17% to $12.89 after Q2, FY23 revenue guidance misses estimates
- 07/20/22
- ACV Auctions announces the launch of its Smart Acquisition Manager
- 10/31/22
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/17/22 Barclays
- Wynn Resorts price target lowered to $70 from $71 at Barclays
- 09/26/22 Jefferies
- Wynn Resorts upgraded to Buy at Jefferies as Macau plans to resume visitation
- 09/26/22 Jefferies
- Las Vegas Sands upgraded to Buy at Jefferies as Macau plans to resume visitation
- 11/16/22 B. Riley
- Cassava Sciences downgraded to Neutral at B. Riley amid limited disclosures
- 11/16/22 B. Riley
- Cassava Sciences downgraded to Neutral from Buy at B. Riley
- 11/08/22 Univest Securities
- Cassava Sciences price target raised to $12 from $8 at Univest Securities
- 08/11/22 B. Riley
- Cassava Sciences price target lowered to $44 from $58 at B. Riley
- 11/10/22 DA Davidson
- Affirm price target lowered to $32 from $50 at DA Davidson
- 11/10/22 Barclays
- Affirm price target lowered to $16 from $29 at Barclays
- 11/09/22 Jefferies
- Affirm price target lowered to $12 from $15 at Jefferies
- 11/09/22 Truist
- Affirm price target lowered to $21 from $30 at Truist
- 10/31/22 TD Cowen
- Cowen starts Freyr Battery at Outperform, sees 'less technology risk'
- 10/31/22 TD Cowen
- Freyr Battery initiated with an Outperform at Cowen
- 09/21/22 Morgan Stanley
- Freyr Battery price target raised to $26, named a 'Top Pick' at Morgan Stanley
- 09/01/22 BTIG
- Freyr Battery price target raised to $25 from $20 at BTIG
- 07/20/22 Deutsche Bank
- Indie Semiconductor price target lowered to $10 from $11 at Deutsche Bank
- 06/15/22 B. Riley
- B. Riley downgrades eight semi stocks on 'demand destruction risk'
- 06/15/22 B. Riley
- Indie Semiconductor downgraded to Neutral from Buy at B. Riley
- 05/13/22 B. Riley
- Indie Semiconductor price target lowered to $9 from $15 at B. Riley
- 10/25/22 UBS
- Nuscale Power initiated with a Neutral at UBS
- 08/25/22 Wells Fargo
- Nuscale Power initiated with an Equal Weight at Wells Fargo
- 08/18/22 Guggenheim
- Guggenheim starts 'unique opportunity' Nuscale Power with Buy, $18 target
- 08/18/22 Guggenheim
- Nuscale Power initiated with a Buy at Guggenheim
- 08/16/22 Credit Suisse
- 3D Systems initiated with an Underperform at Credit Suisse
- 05/11/22 Craig-Hallum
- 3D Systems price target lowered to $10 from $18 at Craig-Hallum
- 05/10/22 BofA
- 3D Systems price target lowered to $12 from $23 at BofA
- 03/01/22 Craig-Hallum
- 3D Systems price target lowered to $18 from $33 at Craig-Hallum
- 08/31/22 Susquehanna
- Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see'
- 08/31/22 Susquehanna
- Paysafe downgraded to Neutral from Positive at Susquehanna
- 08/11/22 Credit Suisse
- Paysafe downgraded to Underperform from Neutral at Credit Suisse
- 08/10/22 RBC Capital
- Paysafe downgraded to Sector Perform from Outperform at RBC Capital
- 11/08/22 Credit Suisse
- Beam Therapeutics price target lowered to $53 from $65 at Credit Suisse
- 08/10/22 Barclays
- Beam Therapeutics price target raised to $60 from $38 at Barclays
- 07/18/22 BMO Capital
- Beam Therapeutics price target raised to $61 from $41 at BMO Capital
- 06/16/22 BMO Capital
- Beam Therapeutics initiated with a Market Perform at BMO Capital
- 11/14/22 Wells Fargo
- Archaea Energy downgraded to Equal Weight from Overweight at Wells Fargo
- 10/04/22 Wells Fargo
- Archaea Energy initiated with an Overweight at Wells Fargo
- 06/17/22 Barclays
- Barclays starts Archaea Energy at Overweight on 'vast' growth potential
- 06/17/22 Barclays
- Archaea Energy initiated with an Overweight at Barclays
- 11/15/22 Credit Suisse
- Monday.com price target lowered to $140 from $180 at Credit Suisse
- 11/15/22 Citi
- Monday.com price target raised to $138 from $135 at Citi
- 11/15/22 Canaccord
- Monday.com price target lowered to $120 from $165 at Canaccord
- 10/21/22 Citi
- Monday.com price target lowered to $135 from $156 at Citi
- 11/16/22 RBC Capital
- Oatly Group price target lowered to $7 from $8 at RBC Capital
- 11/16/22 Mizuho
- Oatly Group price target lowered to $2.50 from $3.50 at Mizuho
- 09/13/22 Credit Suisse
- Oatly Group downgraded to Neutral from Outperform at Credit Suisse
- 08/03/22 RBC Capital
- Oatly Group price target lowered to $9 from $14 at RBC Capital
- 11/14/22 Wedbush
- Zentalis price target lowered to $32 from $51 at Wedbush
- 11/14/22 Wells Fargo
- Zentalis price target lowered to $46 from $52 at Wells Fargo
- 11/10/22 Oppenheimer
- Zentalis price target lowered to $50 from $80 at Oppenheimer
- 08/10/22 SVB Securities
- Zentalis price target lowered to $42 from $67 at SVB Securities
- 10/05/22 Evercore ISI
- Inhibrx price target raised to $60 from $54 at Evercore ISI
- 08/09/22 Credit Suisse
- Inhibrx price target lowered to $48 from $53 at Credit Suisse
- 03/15/22 SMBC Nikko
- Inhibrx initiated with an Outperform at SMBC Nikko
- 03/15/22 SMBC Nikko
- Inhibrx initiated with an Outperform at SMBC Nikko
- 11/10/22 Citi
- ACV Auctions price target lowered to $11 from $13 at Citi
- 11/10/22 Canaccord
- ACV Auctions price target lowered to $12 from $18 at Canaccord
- 10/06/22 Jefferies
- ACV Auctions price target lowered to $15 from $17 at Jefferies
- 06/30/22 JMP Securities
- ACV Auctions price target lowered to $10 from $20 at JMP Securities
- 10/10/22 Jefferies
- Third Harmonic Bio initiated with a Buy at Jefferies
- 07/01/22 H.C. Wainwright
- Celldex price target raised to $73 from $60 at H.C. Wainwright
PCT PureCycle Technologies - 11/11/22 TD Cowen
- PureCycle Technologies price target lowered to $11 from $15 at Cowen
- 09/15/22 Stifel
- PureCycle Technologies initiated with a Buy at Stifel
- 08/15/22 TD Cowen
- PureCycle Technologies price target lowered to $15 from $17 at Cowen
- 03/10/22 Craig-Hallum
- PureCycle Technologies price target lowered to $18 from $26 at Craig-Hallum
- 11/02/22 BofA
- Bilibili downgraded to Neutral at BofA on 'challenging' monetization outlook
- 11/02/22 BofA
- Bilibili downgraded to Neutral from Buy at BofA
- 10/28/22 Barclays
- Bilibili price target lowered to $13 from $21 at Barclays
- 10/27/22 Citi
- Bilibili downgraded to Neutral at Citi due to uncertainty over growth, profit
- 09/01/22 Needham
- Needham says Compass is 'preferred way' to play difficult real estate market
- 08/16/22 Barclays
- Compass price target lowered to $5 from $7 at Barclays
- 07/21/22 Morgan Stanley
- Compass downgraded to Equal Weight from Overweight at Morgan Stanley
- 05/16/22 Oppenheimer
- Compass price target lowered to $9 from $14 at Oppenheimer
- 10/25/22 B. Riley
- New York Mortgage price target lowered to $5 from $5.50 at B. Riley
- 07/17/22 Barclays
- New York Mortgage price target lowered to $3 from $3.50 at Barclays
- 07/17/22 Keefe Bruyette
- New York Mortgage downgraded to Market Perform at Keefe Bruyette
- 04/27/22 Barclays
- New York Mortgage price target lowered to $3.50 from $4 at Barclays
- 11/17/22 Credit Suisse
- Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
- 11/14/22 UBS
- Royal Caribbean price target raised to $76 from $56 at UBS
- 10/21/22 Tigress Financial
- Royal Caribbean shares have upside to $80, says Tigress Financial
- 10/12/22 UBS
- Royal Caribbean price target lowered to $56 from $65 at UBS
- 11/17/22 Stifel
- Unity price target raised to $40 from $30 at Stifel
- 11/15/22 Goldman Sachs
- Unity reinstated with a Neutral at Goldman Sachs
- 11/10/22 DA Davidson
- Unity price target lowered to $40 from $60 at DA Davidson
- 11/10/22 Oppenheimer
- Unity price target lowered to $28 from $60 at Oppenheimer
- 11/11/22 Baird
- Warby Parker price target lowered to $23 from $25 at Baird
- 11/11/22 Citi
- Warby Parker price target lowered to $26 from $29 at Citi
- 07/22/22 Piper Sandler
- Warby Parker initiated with an Overweight at Piper Sandler
- 07/21/22 Goldman Sachs
- Warby Parker price target lowered to $12 from $16 at Goldman Sachs
- 10/13/22 Jefferies
- GameStop transferred with a Hold at Jefferies
- 08/16/22 B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 07/22/22 Wedbush
- GameStop price target lowered to $7.50 from $30 at Wedbush
- 05/26/22 Wedbush
- Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 11/09/22 Bernstein
- Two more states legalize cannabis, $3B added to TAM, says Bernstein
- 11/07/22 Canaccord
- Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
- 11/01/22 Bernstein
- Bernstein starts Canopy Growth at Underperform, sees equity raise
- 11/01/22 Bernstein
- Canopy Growth initiated with an Underperform at Bernstein
- 11/09/22
- Zentalis reports Q3 EPS (96c), consensus ($1.17)
- 11/09/22
- Wynn Resorts reports Q3 EPS ($1.27), consensus ($1.00)
- 11/09/22
- Notable companies reporting after market close
- 08/09/22
- Wynn Resorts reports Q2 EPS ($1.14), consensus (94c)
- 08/09/22
- Notable companies reporting after market close
- 11/10/22
- Warby Parker raises FY22 revenue view to $590M-$596M from $584M-$595M
- 11/10/22
- Warby Parker reports Q3 adjusted EPS 1c, consensus 1c
- 08/11/22
- Warby Parker lowers 2022 revenue view to $584M-$595M from $650M-$660M
- 08/11/22
- Warby Parker reports Q2 EPS (28c) vs. (35c) a year ago
- 11/09/22
- Unity raises FY22 revenue view to $1.365B-$1.385B from $1.3B-$1.35B
- 11/09/22
- Unity sees Q4 revenue $425M-$445M, consensus $384.82M
- 11/09/22
- Unity reports Q3 adjusted EPS (14c), consensus (15c)
- 06/03/22
- Nuscale Power reports revenue of $2.4M for three month period ended March 31
- 11/07/22
- Cassava Sciences reports Q3 EPS (51c), consensus (48c)
- 08/03/22
- Cassava Sciences reports Q2 EPS (48c), consensus (43c)
- 11/03/22
- Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c)
- 11/03/22
- Royal Caribbean reports Q3 adjusted EPS 26c, consensus 19c
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/10/22
- Paysafe sees Q4 revenue $370M-$378M, consensus $370.81M
- 11/10/22
- Paysafe raises FY22 revenue view to $1.48B-$1.49B from $1.47B-$1.49B
- 11/10/22
- Paysafe reports Q3 EPS 0c, consensus 0c
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 09/12/22
- Planet Labs sees Q3 revenue $45M-$48M, consensus $46.6M
- 09/12/22
- Planet Labs reports Q2 EPS (7c), consensus (16c)
- 06/14/22
- Planet Labs sees FY23 revenue $177M-$187M, consensus $181.26M
PCT PureCycle Technologies - 08/11/22
- PureCycle Technologies reports Q2 EPS (9c), consensus (14c)
- 11/14/22
- Oatly Group sees FY22 revenue $700M-$720M, consensus $798.58M
- 11/14/22
- Oatly Group reports Q3 EPS (18c), consensus (11c)
- 08/02/22
- Oatly Group lowers FY22 revenue view to $800M-$830M from $880M-$920M
- 08/02/22
- Oatly Group reports Q2 EPS (12c), consensus (13c)
- 11/02/22
- New York Mortgage reports Q3 EPS (33c), consensus (4c)
- 08/02/22
- New York Mortgage reports Q2 EPS (22c), consensus 1c
- 11/14/22
- Monday.com reports Q3 EP 5c consensus (54c)
- 08/08/22
- Monday.com sees Q3 revenue $130M-$131M, consensus $125.74M
- 08/08/22
- Monday.com reports Q2 EPS (33c), consensus (75c)
- 11/10/22
- Archaea Energy reports Q3 EPS (18c), consensus 7c
- 08/16/22
- Archaea Energy reports Q2 EPS (18c), consensus 10c
- 11/10/22
- Indie Semiconductor sees Q4 revenue growth to roughly $132M AR run-rate
- 11/10/22
- Indie Semiconductor reports Q3 EPS (31c), consensus (11c)
- 08/11/22
- Indie Semiconductor sees Q3 topline growth 140%-150%
- 08/11/22
- Indie Semiconductor reports Q2 EPS (4c) vs 6c last year
- 11/07/22
- Inhibrx reports Q3 EPS (90c), consensus (94c)
- 08/08/22
- Inhibrx reports Q2 EPS (97c), consensus (78c)
- 09/07/22
- GameStop reports Q2 EPS (36c), consensus (38c)
- 06/01/22
- GameStop reports Q1 EPS ($2.08), consensus ($1.45)
- 06/01/22
- Notable companies reporting after market close
- 11/14/22
- Freyr Battery reports Q3 EPS (80c), consensus (30c)
- 08/08/22
- Freyr Battery reports Q2 EPS 4c, consensus (26c)
- 11/08/22
- 3D Systems narrows FY22 revenue view to $535M-$545M from $530M-$570M
- 11/08/22
- 3D Systems reports Q3 adjusted EPS (5c), consensus (7c)
- 08/08/22
- 3D Systems cuts FY22 revenue view to $530M-$570M from $580M-$625M
- 08/08/22
- 3D Systems reports Q2 EPS (7c), consensus 0c
- 11/10/22
- Compass lowers FY22 revenue view to $6.05B-$6.20B from $6.15B-$6.45B
- 11/10/22
- Compass sees Q4 revenue $1.15B-$1.30B, consensus $1.41B
- 11/10/22
- Compass reports Q3 EPS (36c), consensus (34c)
- 08/15/22
- Compass sees FY22 revenue $6.15B-$6.45B, consensus $7.59B
- 11/09/22
- Celldex reports Q3 EPS (57c), consensus (58c)
- 08/08/22
- Celldex reports Q2 EPS (77c) vs. (34c) last year
- 11/09/22
- Canopy Growth reports Q2 adjusted EBITDA (C$78.1M), up 52% y/y
- 10/06/22
- Constellation Brands reports Q2 comparable EPS ex-Canopy losses $3.33
- 08/05/22
- Canopy Growth reports Q1 EPS (C$5.23) vs. C$0.84 a year ago
- 06/30/22
- Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.90
- 09/08/22
- Bilibili sees Q3 revenue RMB 5.6B - RMB 5.8B
- 09/08/22
- Bilibili reports Q2 adjusted EPS (74c), consensus (64c)
- 06/09/22
- Bilibili sees Q2 revenue RMB4.85B-RMB4.95B from RMB5.05B in Q1
- 06/09/22
- Bilibili reports Q1 adjusted EPS (66c), consensus (62c)
- 11/07/22
- Beam Therapeutics reports Q3 EPS ($1.56), consensus ($1.31)
- 08/09/22
- Beam Therapeutics reports Q2 EPS ($1.02), consensus ($1.08)
- 11/08/22
- Affirm sees FY23 revenue $1.60B-$1.68B, consensus $1.71B
- 11/08/22
- Affirm sees Q2 revenue $400M-$420M, consensus $433.6M
- 11/08/22
- Affirm reports Q1 EPS (86c), consensus (83c)
- 11/08/22
- Notable companies reporting after market close
- 11/09/22
- ACV Auctions sees FY22 revenue $ $421M-$424M, consensus $428M
- 11/09/22
- ACV Auctions sees Q4 revenue $97M-$100M, consensus $104.83M
- 11/09/22
- ACV Auctions reports Q3 EPS (15c), consensus (17c)
- 08/10/22
- ACV Auctions cuts FY22 revenue view to $427M-$432M from $452M-$460M
|
Earnings
|
Reports Q3 book value per… Reports Q3 book value per share $3.65. Jason Serrano, Chief Executive Officer and President, commented: "The historic rate volatility witnessed in September that was driven by heightened inflationary fears sharply lowered asset prices across the fixed income markets. Our pivot to effectively halting asset pipeline activity throughout the entirety of the third quarter proved to be appropriate and helped enhance our balance sheet while minimizing book value decline. By constraining strategies that deeply depend on securitization market execution, limiting mark-to-market financing exposure and constructing a short-duration investment portfolio that allows us to maintain elevated unrestricted cash, we are well positioned to quickly rotate and take advantage of the emerging dislocation in this higher rate environment and we believe opportunities in this channel will provide a superior path to capital deployment for attractive risk-adjusted returns. With a strong balance sheet and multiple decades of experience in the distressed investment space, we are prepared for and excited about NYMT's future." ShowHide Related Items >><< - 10/17/22
- New York Mortgage reports book value per share $3.62-$3.66 at Sept. 30
- 10/25/22 B. Riley
- New York Mortgage price target lowered to $5 from $5.50 at B. Riley
- 07/17/22 Barclays
- New York Mortgage price target lowered to $3 from $3.50 at Barclays
- 07/17/22 Keefe Bruyette
- New York Mortgage downgraded to Market Perform at Keefe Bruyette
- 04/27/22 Barclays
- New York Mortgage price target lowered to $3.50 from $4 at Barclays
- 08/02/22
- New York Mortgage reports Q2 EPS (22c), consensus 1c
- 05/03/22
- New York Mortgage reports Q1 EPS ,(22c) consensus 7c
- 09/16/22
- Sell these stocks now, proven algorithm says
- 07/18/22
- What You Missed On Wall Street On Monday
- 07/18/22
- What You Missed On Wall Street This Morning
|